Appropriate Utilization of the Prognostic 40-Gene Expression Profile (40-GEP) Test for Cutaneous Squamous Cell Carcinoma (cSCC) Demonstrated by Clinical Reports and Physician Evaluation of Real-World Cases. J of Skin 2022, 6 (2), s21. https://doi.org/10.25251/skin.6.supp.21.